<DOC>
<DOCNO>en.3.391.232.2007.9.13</DOCNO>
<TITLE> Brokerage upgrades, McDonald's lift market </TITLE>
<TEXT>
 NEW YORK, Sept 13 (bdnews24.com/Reuters) - US stocks rose on Thursday after brokerages upgraded General Motors Corp. and Merck & Co. and McDonald's Corp. boosted its annual dividend by 50 percent. In addition, Countrywide Financial Corp., the biggest US mortgage lender, said it had obtained an additional $12 billion in borrowing capacity, lifting its shares by 7.5 percent to $17.88. Trading is likely to be choppy during the session before the Federal Reserve's interest-rate decision next week and volume lower due to the Jewish New Year. The Dow Jones industrial average was up 71.94 points, or 0.54 percent, at 13,363.59. The Standard & Poor's 500 Index was up 6.22 points, or 0.42 percent, at 1,477.78. The Nasdaq Composite Index was up 2.85 points, or 0.11 percent, at 2,594.92. Stocks also gained on government data that showed initial jobless claims inched up last week but were still below economists' forecasts. "The jobless report was a little better than expected and there's some stock-specific news in some very large companies that was positive and is giving investors a reason to buy while waiting for the Fed," said Richard Sichel, who oversees $1.5 billion as chief investment officer of Philadelphia Trust Co. Shares of McDonald's rose to all-time high after the fast-food chain late on Wednesday increased its dividend and the amount of cash it expects to return to shareholders. For details, see ID:nWEN0928. McDonald's rose 3.5 percent to $53 on the NYSE after hitting $53.73 earlier. Shares of GM, a Dow component, rose 5 percent to $31.83 after Citigroup recommended the shares as a "buy." GM's upgrade helped shares of rival Ford Motor Co., to gain 2 percent to $7.65. Pharmaceutical stocks extended their gains of the past few sessions as blue-chip drug maker Merck was upgraded, lifting its shares 2 percent to $50.66. Isis Pharmaceuticals Inc stock climbed after it said a unit of Johnson & Johnson will pay to license two of Isis' experimental diabetes drugs. Isis rose 6.3 percent $50.59. Shares of Target Corp. rose after the retailer said late on Wednesday it had hired an investment bank to advise it in a review of options for its credit card assets. ID:nN12299262. Target rose 3 percent to $64.62 on the NYSE.
</TEXT>
</DOC>
